Caszyme is a biotech company, based in Vilnius, Lithuania. The company specializes in development and applications of CRISPR Cas technology and aims to develop new discoveries, innovative applications, and top-quality research in the field of CRISPR-based molecular tools. Caszyme seeks to create an outstanding value for researchers and companies practising gene-editing worldwide.
Caszyme offers:
- CRISPR research and development
- Platform of identified and characterized Molecular Tools
- Bioinformatic analysis
- Cas protein purification and analysis
Caszyme offers:
- CRISPR research and development
- Platform of identified and characterized Molecular Tools
- Bioinformatic analysis
- Cas protein purification and analysis
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
-
Company HQ Country:
Lithuania
Year Founded:
2017
Main Therapeutic Focus:
Platform for Therapeutics
Lead Product in Development:
Cas nucleases
Development Phase of Primary Product:
Discovery
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
